The 2009-2014 Outlook for Systemic Broad-And Medium-Spectrum Antibiotic Cephalosporins in Japan

Parker, Philip M.
January 2010
Country Outlook Reports;1/13/2010, pN.PAG
Industry Profile
Several charts on the 2009-2014 outlook for systemic broad-and medium-spectrum antibiotic cephalosporins in several cities of Japan, including Aichi, Akita and Aomori, are presented.


Related Articles

  • Activity of chequerboard combinations of ceftaroline and NXL104 versus β-lactamase-producing Enterobacteriaceae. Mushtaq, S.; Warner, M.; Williams, G.; Critchley, I.; Livermore, D. M. // Journal of Antimicrobial Chemotherapy (JAC);Jul2010, Vol. 65 Issue 7, p1428 

    Background: Ceftaroline is a novel oxyimino-cephalosporin, strongly active against methicillin-resistant staphylococci and pneumococci. It is active against Enterobacteriaceae too, but is labile to common β-lactamases, including AmpC and extended-spectrum types. To counteract these enzymes,...

  • Cephalosporin-resistant Shigella flexneri over 9 years (2001–09) in India. Taneja, Neelam; Mewara, Abhishek; Kumar, Ajay; Verma, Garima; Sharma, Meera // Journal of Antimicrobial Chemotherapy (JAC);Jun2012, Vol. 67 Issue 6, p1347 

    Objectives To determine the pattern and antimicrobial resistance genes of cephalosporin resistance in Shigella flexneri and Shigella dysenteriae over 9 years. Methods Isolates of Shigella (S. flexneri, n = 119 and S. dysenteriae, n = 24) were tested for resistance to ceftriaxone and cefepime by...

  • Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007–08). Morrissey, Ian; Leakey, Anne // Journal of Antimicrobial Chemotherapy (JAC);Jun2012, Vol. 67 Issue 6, p1408 

    Objectives To determine the activity of ceftaroline (the active metabolite of the prodrug ceftaroline fosamil), a new cephalosporin recently approved in the USA for the treatment of community-acquired bacterial pneumonia, against serotyped Streptococcus pneumoniae causing community-acquired...

  • cephalosporin (Major drug group).  // Royal Society of Medicine: Medicines;2002, p147 

    The article presents information on cephalosporin, a group of antibiotic drugs that are chemically part of the beta-lactam class. They are broad-spectrum antibacterial drugs that act against both Gram-positive and Gram-negative bacteria. Their chemical structure bears a strong resemblance to...

  • Surveillance of Broad-Spectrum Antibiotic Prescription in Singaporean Hospitals: A 5-Year Longitudinal Study. Yi-Xin Liew; Krishnan, Prabha; Chay-Leng Yeo; Thean-Yen Tan; Siok-Ying Lee; Wan-Peng Lim; Winnie Lee; Li-Yang Hsu // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    Background: Inappropriate prescription of antibiotics may contribute towards higher levels antimicrobial resistance. A key intervention for improving appropriate antibiotic prescription is surveillance of prescription. This paper presents the results of a longitudinal surveillance of...

  • Effect of Repeated Administration of Cefquinome on Biochemical and Hematological Parameters in Buffalo Calves. Mangal, Mukesh; Sharma, Suresh Kumar // Toxicology International;Jan-Apr2015, Vol. 22 Issue 1, p110 

    Aim: Cefquinome, a fourth generation of cephalosporins have been developed for use in animals. Similar to other species, it may also have some adverse reactions in buffalo calves at therapeutic dosage. In the present study, effect of repeated administration of cefquinome on biochemical and...

  • cephalexin. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p154 

    A definition of the term "cephalexin" is presented. It refers to an alternative spelling of cefalexin, a common cephalosphorin drug.

  • The Fecal Microflora of 1-3-Month-Old Infants during Treatment with Eight Oral Antibiotics. Bennet, R.; Eriksson, M.; Nord, C. E. // Infection;Jun2002, Vol. 30 Issue 3, p158 

    We examined the fecal microflora of 1-3-month-oId infants during treatment with phenoxymethyl penicilIin, amoxycilIin, pivampicilIin, cefaclor, cefadroxil, Ioracarbef, erythromycin or cotrimoxazole. Escherichia coli increased during treatment with penicilIins or cephalosporins, but was not...

  • Fluoroquinolones protective against cephalosporin resistance in gram-negative nosocomial pathogens. Schwaber, Mitchell J.; Cosgrove, Sara E.; Gold, Howard S.; Kaye, Keith S.; Carmeli, Yehuda // Emerging Infectious Diseases;Jan2004, Vol. 10 Issue 1, p94 

    In a matched case-control study, we studied the effect of prior receipt of fluoroquinolones on isolation of three third-generation cephalosporin-resistant gram-negative nosocomial pathogens. Two hundred eighty-two cases with a third-generation cephalosporin-resistant pathogen (203 with...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics